In recent years, the incidence of thyroid cancer has risen significantly worldwide, particularly among women. This trend raises an important question: Is thyroid cancer truly becoming more common, or are we simply detecting it more effectively?Experts generally agree that the apparent increase is largely due to advances in medical diagnostics rather than a true surge in disease. High-resolution ultrasound and fine-needle aspiration biopsy now detect numerous small, asymptomatic thyroid nodules—many of which are papillary microcarcinomas that may never cause harm during a person’s lifetime. This phenomenon is known as ‘overdiagnosis.’Additionally, greater public awareness and widespread health screenings have led more people to undergo thyroid examinations. While known risk factors such as radiation exposure (especially during childhood), genetic predisposition, and abnormal iodine intake do contribute to thyroid cancer, they cannot fully account for the rapid rise in diagnoses over recent decades.Notably, despite the sharp increase in diagnosed cases, mortality rates from thyroid cancer have remained stable or even slightly declined—further supporting the view that most newly identified cases are low-risk tumors. Therefore, while the rising incidence warrants attention, there’s no need for alarm. Individuals should approach screening results rationally and, under medical guidance, decide whether treatment is truly necessary to avoid unnecessary surgery and psychological stress.
近年来，甲状腺癌的发病率在全球范围内显著上升，尤其在女性中更为明显。这一趋势引发广泛关注：究竟是甲状腺癌真的变多了，还是我们‘看得更清楚’了？专家普遍认为，甲状腺癌‘增多’的主要原因并非环境或生活方式剧变，而是医学检测技术的进步。高分辨率超声、细针穿刺活检等手段使得大量微小、无症状甚至终身不会造成危害的甲状腺结节被发现并诊断为癌症（尤其是乳头状微小癌）。这种现象被称为‘过度诊断’。此外，公众健康意识提升、体检普及也促使更多人主动筛查甲状腺问题。虽然辐射暴露（如儿童期接受颈部放疗）、遗传因素和碘摄入异常等确实与甲状腺癌有关，但它们无法完全解释近几十年来发病率的快速攀升。值得注意的是，尽管确诊人数激增，但甲状腺癌的死亡率却保持稳定甚至略有下降，这进一步支持‘多数新增病例为低风险肿瘤’的观点。因此，面对甲状腺癌‘高发’，公众无需恐慌，但应理性对待筛查结果，在医生指导下决定是否需要治疗，避免不必要的手术和心理负担。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/1112.html